Cell Reports (Jun 2020)

Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation

  • Karpagam Srinivasan,
  • Brad A. Friedman,
  • Ainhoa Etxeberria,
  • Melanie A. Huntley,
  • Marcel P. van der Brug,
  • Oded Foreman,
  • Jonathan S. Paw,
  • Zora Modrusan,
  • Thomas G. Beach,
  • Geidy E. Serrano,
  • David V. Hansen

Journal volume & issue
Vol. 31, no. 13
p. 107843

Abstract

Read online

Summary: Damage-associated microglia (DAM) profiles observed in Alzheimer’s disease (AD)-related mouse models reflect an activation state that could modulate AD risk or progression. To learn whether human AD microglia (HAM) display a similar profile, we develop a method for purifying cell types from frozen cerebrocortical tissues for RNA-seq analysis, allowing better transcriptome coverage than typical single-nucleus RNA-seq approaches. The HAM profile we observe bears little resemblance to the DAM profile. Instead, HAM display an enhanced human aging profile, in addition to other disease-related changes such as APOE upregulation. Analyses of whole-tissue RNA-seq and single-cell/nucleus RNA-seq datasets corroborate our findings and suggest that the lack of DAM response in human microglia occurs specifically in AD tissues, not other neurodegenerative settings. These results, which can be browsed at http://research-pub.gene.com/BrainMyeloidLandscape, provide a genome-wide picture of microglial activation in human AD and highlight considerable differences between mouse models and human disease.

Keywords